Koyfin Home > Directory > Health Care > Anika Therapeutics > Price / Earnings (ntm)

Anika Therapeutics Price / Earnings (ntm) Chart (ANIK)

Anika Therapeutics annual/quarterly Price / Earnings (ntm) from 2011 to 2020. The price-earnings ratio (P/E ratio) is the ratio for valuing a company that measures its current share price relative to its consensus EPS estimate of the next twelve months (NTM). The price-earnings ratio is also sometimes known as the price multiple or the earnings multiple.
  • Anika Therapeutics Price / Earnings (ntm) for the quarter ending October 10, 2020 was 57.98 a -5.61% decrease of -3.25 year over year
  • Anika Therapeutics Price / Earnings (ntm) for the last 12 months ending October 10, 2020 was 57.98 a -5.61% decrease of -3.25 year over year
  • Anika Therapeutics Annual Price / Earnings (ntm) for 2020 was 57.98 a -3.18% decrease of -1.84 from 2019
  • Anika Therapeutics Annual Price / Earnings (ntm) for 2020 was 59.83 a -0.70% decrease of -0.42 from 2019
  • Anika Therapeutics Annual Price / Earnings (ntm) for 2020 was 60.24 a -1.65% decrease of -0.99 from 2019
Other Valuation Metrics:
  • Anika Therapeutics Market Cap for the quarter ending June 06, 2018 was $458m a -85.66% decrease of -392m year over year
  • Anika Therapeutics Price / Book for the quarter ending June 06, 2018 was 1.79 a -94.67% decrease of -1.69 year over year
  • Anika Therapeutics Enterprise Value for the quarter ending June 06, 2018 was $295m a -139.86% decrease of -412m year over year
View Chart On Koyfin

Quarterly ANIK Price / Earnings (ntm) Data

10/202057.98
10/202059.83
10/202060.24
10/202061.23
10/202062.50
10/202062.31
10/202062.83
10/202065.77
10/202067.04
10/202066.71

Annual ANIK Price / Earnings (ntm) Data

202057.98
202059.83
202060.24
202061.23
202062.50
202062.31
202062.83
202065.77
202067.04
202066.71